Genetics and PARP Inhibitors

Moderators: Amanika Kumar, MD, Jamie Bakkum-Gamez, MD
Presenters: Myra Wick, MD, Andrea Wahner Hendrickson, MD, Teri Woodhull

Register Here

Join Dr. Myra Wick, Dr. Andrea Wahner Hendrickson and Teri Woodhull for an in-depth discussion on the importance of genetics and genetic testing in ovarian cancer and the implications for treatment, with special attention to PARP inhibitors. They will discuss different options for genetic testing, indications for PARP inhibitors and how to make a decision regarding PARP inhibitor treatment or maintenance. Teri Woodhull will discuss the experience of being on an inhibitor including risks and side effects.

This webinar is being put on in collaboration with:

This webinar is made possible through sponsorship support from: